GlobeNewswire 2021-11-30 Neovasc Reducer™ System Receives National Reimbursement in France
GlobeNewswire 2021-11-24 Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
GlobeNewswire 2021-11-24 The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidan...
GlobeNewswire 2021-11-09 Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-11-01 Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
GlobeNewswire 2021-10-21 Neovasc Reducer™ Featured in Polish Heart Journal
GlobeNewswire 2021-09-28 Neovasc REDUCER-I Study Published in EuroIntervention Journal
GlobeNewswire 2021-09-23 Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
GlobeNewswire 2021-09-16 Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
GlobeNewswire 2021-08-30 Neovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment Conference
GlobeNewswire 2021-08-17 Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA
GlobeNewswire 2021-08-10 Neovasc Announces Second Quarter 2021 Financial Results
GlobeNewswire 2021-07-27 Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
GlobeNewswire 2021-07-13 Neovasc Announces New Appointments in Regulatory and Clinical Leadership
GlobeNewswire 2021-06-18 Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in In...
GlobeNewswire 2021-06-18 Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in In...
GlobeNewswire 2021-06-10 Neovasc Provides Corporate Update
GlobeNewswire 2021-06-07 Neovasc Reducer System Receives First National Reimbursement in Europe
GlobeNewswire 2021-06-03 Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
GlobeNewswire 2021-05-25 Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency 
GlobeNewswire 2021-05-20 Neovasc Provides Update on German Litigation
GlobeNewswire 2021-05-13 Neovasc to Sponsor Symposium on Reducer at EuroPCR
GlobeNewswire 2021-05-10 Neovasc Announces First Patient Enrollment in COSIMA Trial
GlobeNewswire 2021-05-06 Neovasc Announces First Quarter 2021 Financial Results
GlobeNewswire 2021-04-28 Neovasc Provides Reducer Reimbursement Progress Update